AdaptHealth Names New CEO and CFO
Ticker: AHCO · Form: 8-K · Filed: Aug 19, 2024 · CIK: 1725255
Sentiment: neutral
Topics: leadership-change, executive-appointments, management-transition
TL;DR
AdaptHealth officially names Jason Hannon as CEO and Mark Hanley as CFO, effective immediately.
AI Summary
AdaptHealth Corp. announced on August 13, 2024, the appointment of Jason M. Hannon as Chief Executive Officer, effective immediately. Hannon, previously the interim CEO, will also join the Board of Directors. The company also announced the departure of its former CEO, David L. Bercaw, and the appointment of Mark J. Hanley as Chief Financial Officer.
Why It Matters
This filing signifies a leadership transition at AdaptHealth, with a new permanent CEO and CFO taking the helm, which could impact the company's strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, potentially impacting investor confidence.
Key Players & Entities
- AdaptHealth Corp. (company) — Registrant
- Jason M. Hannon (person) — Appointed Chief Executive Officer and Board Member
- David L. Bercaw (person) — Departed Chief Executive Officer
- Mark J. Hanley (person) — Appointed Chief Financial Officer
- August 13, 2024 (date) — Effective date of appointments and departures
FAQ
Who has been appointed as the new CEO of AdaptHealth Corp.?
Jason M. Hannon has been appointed as the new Chief Executive Officer of AdaptHealth Corp., effective August 13, 2024.
Who is the new Chief Financial Officer?
Mark J. Hanley has been appointed as the Chief Financial Officer of AdaptHealth Corp.
Who previously held the CEO position?
David L. Bercaw previously held the CEO position and has departed the company.
When were these leadership changes effective?
The leadership changes were effective as of August 13, 2024.
Will the new CEO also join the Board of Directors?
Yes, Jason M. Hannon, the newly appointed CEO, will also join the Board of Directors.
Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-08-19 17:03:32
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share AHCO The Nasdaq Stock Mar
Filing Documents
- tm2422042d1_8k.htm (8-K) — 25KB
- 0001104659-24-090892.txt ( ) — 194KB
- ahco-20240813.xsd (EX-101.SCH) — 3KB
- ahco-20240813_lab.xml (EX-101.LAB) — 33KB
- ahco-20240813_pre.xml (EX-101.PRE) — 22KB
- tm2422042d1_8k_htm.xml (XML) — 4KB
02. Departure of Directors or Certain
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2024, AdaptHealth Corp. (the "Company") informed Shaw Rietkerk of its intention to transition him to a new position as the Company's Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company's Chief Operating Officer. The Company and Mr. Rietkerk are currently negotiating the terms of the transition. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: August 19, 2024 AdaptHealth Corp. By: /s/ Jonathan B. Bush Name: Jonathan B. Bush Title: General Counsel - 2 -